Literature DB >> 71881

[Investigations about the incorporation of nucleotide precursors in single cell suspensions of ovarian- and cervix-carcinomas under the influence of cytostatic therapy (author's transl)].

G Teufel, A Pfleiderer, O Doerjer, J Weigand.   

Abstract

The behaviour of 34 carcinomas of the cervix and 30 ovarian carcinomas under the influence of cytostatic agents was investigated in vitro by the method of Volm et al. The ovarian carcinomas showed a significantly higher incorporation rate of nucleotide precursors in the single cell suspensions. The incorporation rate in "chemosensitive" carcinomas was higher than in "chemoresistent" carcinomas independent of the type of the carcinomas. Carcinomas with a high decrease in incorporation rates of nucleotide precursors under the influence of cytostatic drugs were called chemosensitive. A cyclophosphamide-sensitivity in vitro was found in 9% of the carcinomas of the cervix and in 34% of the ovarian carcinomas. An adriamycin-sensitivity in vitro could be shown in 17% of the carcinomas of the cervix and in 46% of the ovarian carcinomas. These findings agree well with the experiences of cytostatic therapy of these carcinomas.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71881     DOI: 10.1007/BF00667113

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  14 in total

1.  [Treatment of advanced inoperable carcinoma of the ovaries (author's transl)].

Authors:  H J Senn
Journal:  Ther Umsch       Date:  1973-09

2.  [Selective tumour chemotherapy using oncobiograms (author's transl)].

Authors:  M Volm; M Kaufmann; K Wayss; K Goerttler; J Mattern
Journal:  Dtsch Med Wochenschr       Date:  1974-01-11       Impact factor: 0.628

3.  Systemic chemotherapy for carcinoma of the cervix.

Authors:  J P Smith; F Rutledge; B C Burns; S Soffar
Journal:  Am J Obstet Gynecol       Date:  1967-03-15       Impact factor: 8.661

4.  [The treatment of ovarian carcinoma in the Univ.-Frauenklinik Tübingen since 1957 and its results].

Authors:  A Pfleiderer; S Kiyan
Journal:  Med Welt       Date:  1967-12-23

5.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

6.  [The problems of prophylactic chemotherapy, the second-look operation and the maintenance of the remission in the treatment of ovarian cancer (author's transl)].

Authors:  A Pfleiderer
Journal:  Geburtshilfe Frauenheilkd       Date:  1976-02       Impact factor: 2.915

7.  [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].

Authors:  G Teufel; A Pfleiderer
Journal:  Geburtshilfe Frauenheilkd       Date:  1976-03       Impact factor: 2.915

8.  [In-vitro testing of the sensitivity of mammary carcinoma cells to cytostatic drugs (author's transl)].

Authors:  G Bastert; H Schmidt-Matthiesen; R Gerner; R T Michel; D Nord; G Leppien
Journal:  Dtsch Med Wochenschr       Date:  1975-10-03       Impact factor: 0.628

9.  [Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].

Authors:  M Volm; M Kaufmann; J Mattern; K Wayss
Journal:  Schweiz Med Wochenschr       Date:  1975-01-18

10.  [Studies on the spontaneous decomposition of 4-hydroxyphosphamide and 4-hydroperoxyphosphamide by means of thin-layer chromatography].

Authors:  G Völker; U Dräger; G Peter; H J Hohorst
Journal:  Arzneimittelforschung       Date:  1974-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.